None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy adults in the age group of 18 and 45 years – male and female -1:1 ratio Fasting blood glucose levels more than 100mg perdL. BMI should be between 18.5 to 23 kg per m2 Lipid profile (Total cholesterol) within normal range as applicable Agree to participate in the study. Able and willing to follow all study related instructions. Must be willing to give written informed consent and comply with the study procedures. Subject’s complete blood count parameters to be within clinically acceptable range by Investigator.
Exclusion criteria
Exclusion criteria: Subjects with BMI less than 18.5kg per m2 or more than 23 kg per m2 will be excluded from the study. Total cholesterol higher than normal range. Subjects particularly on any special diet Subjects suffering from any systemic disorders (diabetes, cardiovascular, renal, pulmonary, endocrine, or neurological disorders, ulcers, dermatologic disorders, autoimmune diseases) or severe food allergies; an active infectious disease (HBV, HCV, HIV) urrent diagnosis or a history of relevant depressive episodes or of panic attacks, psychosis, bipolar or eating disorders Pregnant or lactating women Patient having participated in any other clinical trial within one month prior to screening
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess glycemic index using blood sugar levels measured at fixed intervals (-5 15 30 45 60 90 and 120 min) in a day with respect to reference productTimepoint: -5 15 30 45 60 90 and 120 min | — |
Secondary
| Measure | Time frame |
|---|---|
| - To assess change in hematological and biochemical parameters from baseline to end of the study. - Assessment adverse events during the study period.Timepoint: At baseline & end of the Study | — |
Countries
India
Contacts
Amway Global Services India Pvt Ltd